CERo Therapeutics Holdings Inc.

NASDAQ:CERO 4:00:00 PM EDT

8.00

+0.27 (+3.49%)

7:54:15 PM EDT: $8.07 +0.07 (+0.88%)

CERo Therapeutics Holdings Inc. Stock, NASDAQ:CERO

201 Haskins Way, Suite 230, Oakland, California 94080

United States of America

Phone: +1.215.731.9450

Number of Employees: 9

http://www.cero.bio

Description

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.